F Hoffmann La Roche Chugai Pharmaceutical competitive analysis

Explore patent oppositions filed by F Hoffmann La Roche Chugai Pharmaceutical against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
Prolongation Of Survival Of An Allograft By Inhibiting Complement ActivityALEXION PHARMACEUTICALSSep 12, 2015
Prolongation Of Survival Of An Allograft By Inhibiting Complement ActivityALEXION PHARMACEUTICALSAug 18, 2015

Latest PTAB cases involving F Hoffmann La Roche Chugai Pharmaceutical

Discover the latest PTAB cases involving F Hoffmann La Roche Chugai Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing F Hoffmann La Roche Chugai Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
F HOFFMANN LA ROCHE CHUGAI PHARMACEUTICAL2 - - -
ALEXION PHARMACEUTICALS515 - 8
THE UNIVERSITY OF WESTERN ONTARIO - 2 - -